ORTHOGENRX Trademark

Trademark Overview


On Wednesday, July 26, 2017, a trademark application was filed for ORTHOGENRX with the United States Patent and Trademark Office. The USPTO has given the ORTHOGENRX trademark a serial number of 87543190. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, August 5, 2024. This trademark is owned by OrthogenRx, Inc.. The ORTHOGENRX trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal therapeutic preparations for the treatment of diseases of the joint
orthogenrx

General Information


Serial Number87543190
Word MarkORTHOGENRX
Filing DateWednesday, July 26, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, August 5, 2024
Registration Number5406855
Registration DateTuesday, February 20, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 5, 2017

Trademark Statements


Description of MarkThe mark consists of a stylized body in the shape of an upward swooping line and a downward swooping line to form an X, with a circle placed above where the lines converge. The word ORTHOGENRX is underneath, with the downward swoop crossing to form the X in ORTHOGENRX.
Goods and ServicesMedicinal therapeutic preparations for the treatment of diseases of the joint
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 29, 2017
Primary Code005
First Use Anywhere DateMonday, March 21, 2016
First Use In Commerce DateMonday, March 21, 2016

Trademark Owner History


Party NameAVANOS MEDICAL SALES, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressALPHARETTA, GA 30004

Party NameOrthogenRx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDoylestown, PA 18901

Party NameOrthogenRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDoylestown, PA 18902

Party NameOrthogenRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDoylestown, PA 18902

Trademark Events


Event DateEvent Description
Saturday, July 29, 2017NEW APPLICATION ENTERED
Friday, January 18, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, July 29, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 1, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 26, 2017ASSIGNED TO EXAMINER
Monday, October 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2018REGISTERED-PRINCIPAL REGISTER
Friday, January 18, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 11, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 11, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 5, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 5, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 5, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, March 13, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, February 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, January 18, 2024TEAS SECTION 8 & 15 RECEIVED